# US 2022/0009967 A1 · Isolation and Semi-Synthesis of Rufomycin Analogs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0009967 A1
- Document ID: US20220009967A1
- Status: Published application
- Kind: A1
- Application number: 17/305,713
- Filed: 2021-07-13
- Published: 2022-01-13
- Earliest claimed: 2020-07-13
- Assignees: The Board of Trustees of the University of Illinois
- Applicants: The Board of Trustees of the University of Illinois
- Inventors: Scott G. Franzblau
- Web page: https://patentgrep.com/patent/US20220009967A1

## CPC

- C07K 7/64: Cyclic peptides containing only normal peptide links
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61P 31/06: for tuberculosis
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided herein are compounds having a structure according to formula I, pharmaceutical compositions thereof, and methods of treating a bacterial infection thereof.

## Claims

### Claim 1

A compound having a structure according to Formula I or a pharmaceutically acceptable salt thereof:
wherein,
R1 and R2, together are selected from
R3 and R4 are independently selected from NO2, OH, OAc, OCH3, OBz, NH2, and
or R3 and R4 together with the carbon atoms to which they are attached, form a five- to seven-membered substituted or unsubstituted heterocycloalkyl comprising 1 to 3 ring heteroatoms selected from O and N;
R5 is selected from
and,
R6 is selected from H and C1-C3 alkyl;
provided when R1 and R2 together are
R3 is NO2, R4 is OH, and R5 is
that R6 is not H; when R1 and R2 together are
R3 is NO2, R4 is OH, and R5 is
that R6 is not H; when R1 and R2 together are
R3 is NO2, R4 is OH, and R5 is
that R6 is not H; and when R1 and R2 together are
R3 is NO2, R4 is OH, and R5 is
that R6 is not H.

### Claim 2 (depends on 1)

The compound of claim 1, wherein R1 and R2 together are selected from

### Claim 3 (depends on 2)

The compound of claim 2, wherein R1 and R2 together are selected from

### Claim 4 (depends on 1)

The compound of claim 1, wherein R3 is NO2, NH2, or

### Claim 5 (depends on 4)

The compound of claim 4, wherein R3 is NO2.

### Claim 6 (depends on 1)

The compound of claim 1, wherein R4 is OH, OAc, OCH3, or OBz.

### Claim 7 (depends on 1)

The compound of claim 1, wherein R4 is OH, OAc, or OCH3.

### Claim 8 (depends on 1)

The compound of claim 1, wherein R3 and R4 together are selected from

### Claim 9 (depends on 1)

The compound of claim 1, wherein R5 is selected from

### Claim 10 (depends on 1)

The compound of claim 1, wherein R6 is H or CH3.

### Claim 11 (depends on 1)

The compound of claim 1, wherein R6 is H.

### Claim 12 (depends on 1)

The compound of claim 1 selected from the group of:

### Claim 13

A compound or a pharmaceutically acceptable salt thereof having a structure selected from the group of

### Claim 14 (depends on 1)

A method of treating a bacterial infection or prophylaxis of a bacterial infection, comprising administering to a subject in need thereof a therapeutically effective amount of a compound according to claim 1, or a pharmaceutically acceptable salt thereof.

### Claim 15 (depends on 14)

The method of claim 14, wherein the bacterial infection is due to Mycobacterium tuberculosis.

### Claim 16 (depends on 15)

The method of claim 15, wherein the Mycobacterium tuberculosis is a drug resistant Mycobacterial strain.

### Claim 17 (depends on 1)

A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 1, or a pharmaceutically acceptable salt thereof, and an excipient.

### Claim 18 (depends on 13)

A method of treating a bacterial infection or prophylaxis of a bacterial infection, comprising administering to a subject in need thereof a therapeutically effective amount of a compound according to claim 13, or a pharmaceutically acceptable salt thereof.

### Claim 19 (depends on 18)

The method of claim 18, wherein the bacterial infection is due to Mycobacterium tuberculosis.

### Claim 20 (depends on 19)

The method of claim 19, wherein the Mycobacterium tuberculosis is a drug resistant Mycobacterial strain.
